Human papillomavirus-associated squamous cell carcinoma of the upper aerodigestive tract

American Journal of Surgical Pathology

Volumn 34, Issue 7, 2010, Pages

  Stelow, Edward B ^a   Jo, Vickie Y ^a   Stoler, Mark H ^a   Mills, Stacey E ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

basaloid; nonkeratinizing; papillary; sinonasal; tongue; tonsil; undifferentiated

Indexed keywords

ADENOID CYSTIC CARCINOMA; ARTICLE; CARCINOMA; DIFFERENTIAL DIAGNOSIS; FEMALE; HEAD AND NECK TUMOR; HUMAN; HYPOPHARYNX TUMOR; ISOLATION AND PURIFICATION; LARYNX TUMOR; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OROPHARYNX TUMOR; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PROGNOSIS; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; VIROLOGY;

CARCINOMA, ADENOID CYSTIC; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS;

EID: 77954212777     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181e21478     Document Type: Article

References (81)

1. Abramson AL, Brandsma J, Steinberg B, et al. Verrucous carcinoma of the larynx. Possible human papillomavirus etiology. Arch Otolaryngol. 1985;111:709-715.
2. Allen MS Jr, Marsh WL Jr. Lymph node involvement by direct extension in adenoid cystic carcinoma. Absence of classic embolic lymph node metastasis. Cancer. 1976;38:2017-2021.
3. Banks ER, Frierson HF Jr, Mills SE, et al. Basaloid squamous cell carcinoma of the head and neck. A clinicopathologic and immuno-histochemical study of 40 cases. Am J Surg Pathol. 1992;16:939-946.
4. Begum S, Westra WH. Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. Am J Surg Pathol. 2008;32:1044-1050.
5. Begum S, Gillison ML, Nicol TL, et al. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res. 2007;13:1186-1191.
6. Brandsma JL, Abramson AL. Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg. 1989;115:621-625.
7. Brandsma JL, Steinberg BM, Abramson AL, et al. Presence of human papillomavirus type 16 related sequences in verrucous carcinoma of the larynx. Cancer Res. 1986;46:2185-2188.
8. Chapman-Fredricks J, Jorda M, Gomez-Fernandez C. A limited immunohistochemical panel helps differentiate small cell epithelial malignancies of the sinonasal cavity and nasopharynx. Appl Immunohistochem Mol Morphol. 2009;17:207-210.
9. Chaturvedi AK, Engels EA, Anderson WF, et al. Incidence trends for human papillomavirus-related and-unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26:612-619.
10. Chen JC, Gnepp DR, Bedrossian CW. Adenoid cystic carcinoma of the salivary glands: an immunohistochemical analysis. Oral Surg Oral Med Oral Pathol. 1988;65:316-326.
11. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944-1956.
12. Depue RH. Rising mortality from cancer of the tongue in young white males. N Engl J Med. 1986;315:647.
13. Devaraj K, Gillison ML, Wu TC. Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma. Crit Rev Oral Biol Med. 2003;14:345-362.
14. El-Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2003;27:1463-1470.
15. El-Mofty SK, Lu DW. Prevalence of high-risk human papilloma-virus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2005;29:1367-1372.
16. El-Mofty SK, Patil S. Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:339-345.
17. Ellis GL, Wiscovitch JG. Basal cell adenocarcinomas of the major salivary glands. Oral Surg Oral Med Oral Pathol. 1990;69:461-469.
18. Emanuel P, Wang B, Wu M, et al. p63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma. Mod Pathol. 2005;18:645-650.
19. Ereno C, Lopez JI, Sanchez JM, et al. Basaloid-squamous cell carcinoma of the larynx and hypopharynx. A clinicopathologic study of 7 cases. Pathol Res Pract. 1994;190:186-193.
20. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261-269.
21. Fliss DM, Noble-Topham SE, McLachlin M, et al. Laryngeal verrucous carcinoma: a clinicopathologic study and detection of human papillomavirus using polymerase chain reaction. Laryngoscope. 1994;104:146-152.
22. Fonseca I, Soares J. Basal cell adenocarcinoma of minor salivary and seromucous glands of the head and neck region. Semin Diagn Pathol. 1996;13:128-137.
23. Gillison ML. Current topics in the epidemiology of oral cavity and oropharyngeal cancers. Head Neck. 2007;29:779-792.
24. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709-720.
25. Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008;113:3036-3046.
26. Gnepp DR, Wick MR. Small cell carcinoma of the major salivary glands. An immunohistochemical study. Cancer. 1990;66:185-192.
27. Goldenberg D, Begum S, Westra WH, et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck. 2008;30:898-903.
28. Hagen P, Lyons GD, Haindel C. Verrucous carcinoma of the larynx: role of human papillomavirus, radiation, and surgery. Laryngoscope. 1993;103:253-257.
29. Jayakrishnan A, Elmalah I, Hussain K, et al. Basal cell adenocarci-noma in minor salivary glands. Histopathology. 2003;42:610-614.
30. Jo VY, Mills SE, Stoler MH, et al. Papillary squamous cell carcinoma of the head and neck: frequent association with human papillomavirus infection and invasive carcinoma. Am J Surg Pathol. 2009;33:1720-1724.
31. Kleist B, Bankau A, Lorenz G, et al. Different risk factors in basa-loid and common squamous head and neck cancer. Laryngoscope. 2004;114:1063-1068.
32. Kumar B, Cordell KG, Lee JS, et al. Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. Int J Radiat Oncol Biol Phys. 2007;69:S109-S111.
33. Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008;26:3128-3137.
34. Lee WT, Tubbs RR, Teker AM, et al. Use of in situ hybridization to detect human papillomavirus in head and neck squamous cell carcinoma patients without a history of alcohol or tobacco use. Arch Pathol Lab Med. 2008;132:1653-1656.
35. Li W, Thompson CH, O'Brien CJ, et al. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer. 2003;106:553-558.
36. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006;24:5630-5636.
37. Lindel K, Beer KT, Laissue J, et al. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer. 2001;92:805-813.
38. Lo Muzio L, D'Angelo M, Procaccini M, et al. Expression of cell cycle markers and human papillomavirus infection in oral squamous cell carcinoma: use of fuzzy neural networks. Int J Cancer. 2005;115: 717-723.
39. Lopez-Amado M, Garcia-Caballero T, Lozano-Ramirez A, et al. Human papillomavirus and p53 oncoprotein in verrucous carcinoma of the larynx. J Laryngol Otol. 1996;110:742-747.
40. Luna MA, el Naggar A, Parichatikanond P, et al. Basaloid squa-mous carcinoma of the upper aerodigestive tract. Clinicopathologic and DNA flow cytometric analysis. Cancer. 1990;66:537-542.
41. Marsh WL Jr, Allen MS Jr. Adenoid cystic carcinoma: biologic behavior in 38 patients. Cancer. 1979;43:1463-1473.
42. Masih AS, Stoler MH, Farrow GM, et al. Penile verrucous carcinoma: a clinicopathologic, human papillomavirus typing and flow cytometric analysis. Mod Pathol. 1992;5:48-55.
43. Mellin H, Friesland S, Lewensohn R, et al. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2000;89:300-304.
44. Micheau C, Cachin Y, Caillou B. Cystic metastases in the neck revealing occult carcinoma of the tonsil. A report of six cases. Cancer. 1974;33:228-233.
45. Mills SE, Cooper PH, Garland TA, et al. Small cell undifferentiated carcinoma of the larynx. Report of two patients and review of 13 additional cases. Cancer. 1983;51:116-120.
46. Mino M, Pilch BZ, Faquin WC. Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma. Mod Pathol. 2003;16:1224-1231.
47. Miralles-Guri C, Bruni L, Cubilla AL, et al. Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol. 2009;62:870-878.
48. Nichols AC, Faquin WC, Westra WH, et al. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2009;140:228-234.
49. Niedobitek G, Pitteroff S, Herbst H, et al. Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. J Clin Pathol. 1990;43:918-921.
50. Orvidas LJ, Lewis JE, Olsen KD, et al. Intranasal verrucous carcinoma: relationship to inverting papilloma and human papillo-mavirus. Laryngoscope. 1999;109:371-375.
51. Pai SI, Westra WH. Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol. 2009;4:49-70.
52. Pai RK, Erickson J, Pourmand N, et al. p16(INK4A) immuno-histochemical staining may be helpful in distinguishing branchial cleft cysts from cystic squamous cell carcinomas originating in the oropharynx. Cancer Cytopathol. 2009;117:108-119.
53. Paz IB, Cook N, Odom-Maryon T, et al. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer. 1997; 79:595-604.
54. Perrone F, Suardi S, Pastore E, et al. Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma. Clin Cancer Res. 2006;12:6643-6651.
55. Quddus MR, Henley JD, Affify AM, et al. Basal cell adenocarci-noma of the salivary gland: an ultrastructural and immunohisto-chemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;87:485-492.
56. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007;121:1813-1820.
57. Ragin CC, Taioli E, Weissfeld JL, et al. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer. 2006;95: 1432-1438.
58. Raslan WF, Barnes L, Krause JR, et al. Basaloid squamous cell carcinoma of the head and neck: a clinicopathologic and flow cytometric study of 10 new cases with review of the English literature. Am J Otolaryngol. 1994;15:204-211.
59. Ritchie JM, Smith EM, Summersgill KF, et al. Human papilloma-virus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer. 2003;104:336-344.
60. Ryerson AB, Peters ES, Coughlin SS, et al. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer. 2008;113:2901-2909.
61. Schantz SP, Byers RM, Goepfert H. Tobacco and cancer of the tongue in young adults. JAMA. 1988;259:1943-1944.
62. Sedaghat AR, Zhang Z, Begum S, et al. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope. 2009;119:1542-1549.
63. Serrano MF, El-Mofty SK, Gnepp DR, et al. Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck. Hum Pathol. 2008;39:591-598.
64. Shemen LJ, Klotz J, Schottenfeld D, et al. Increase of tongue cancer in young men. JAMA. 1984;252:1857.
65. Singhi AD, Westra WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer. 2010;116:2166-2173.
66. Singhi AD, Stelow EB, Mills SE, et al. Lymphoepithelial-like carcinoma of the oropharynx, a morphologic variant of HPV-related head and neck carcinoma. Am J Surg Pathol. 2010. In press.
67. Smith EM, Ritchie JM, Summersgill KF, et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyn-geal cancers. Int J Cancer. 2004;108:766-772.
68. Snijders PJ, Cromme FV, van den Brule AJ, et al. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer. 1992;51:845-850.
69. Stelow EB, Mills SE. Squamous cell carcinoma variants of the upper aerodigestive tract. Am J Clin Pathol. 2005;124(suppl):S96-S109.
70. Stelow EB, Skeate R, Wahi MM, et al. Invasive cutaneous verruco-cystic squamous cell carcinoma. A pattern commonly present in transplant recipients. Am J Clin Pathol. 2003;119:807-810.
71. Stoler MH. Human papillomaviruses and cervical neoplasia: a model for carcinogenesis. Int J Gynecol Pathol. 2000;19:16-28.
72. Stoler MH, Rhodes CR, Whitbeck A, et al. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol. 1992;23:117-128.
73. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer. 2007;110: 1429-1435.
74. Thompson LD, Heffner DK. The clinical importance of cystic squa-mous cell carcinomas in the neck: a study of 136 cases. Cancer. 1998; 82:944-956.
75. Trottier H, Burchell AN. Epidemiology of mucosal human papillo-mavirus infection and associated diseases. Public Health Genomics. 2009;12:291-307.
76. Vidal L, Gillison ML. Human papillomavirus in HNSCC: recognition of a distinct disease type. Hematol Oncol Clin North Am. 2008; 22:1125-1142, vii.
77. Wain SL, Kier R, Vollmer RT, et al. Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases. Hum Pathol. 1986;17:1158-1166.
78. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyn-geal cancers with favorable prognosis. J Clin Oncol. 2006;24: 736-747.
79. Westra WH, Taube JM, Poeta ML, et al. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2008;14:366-369.
80. Wilczynski SP, Lin BT, Xie Y, et al. Detection of human papilloma-virus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol. 1998;152:145-156.
81. Young SK, Min KW. In situ DNA hybridization analysis of oral papillomas, leukoplakias, and carcinomas for human papilloma-virus. Oral Surg Oral Med Oral Pathol. 1991;71:726-729.